Patient-reported outcome results of phase III tesamorelin trials reported by Theratechnologies Oct. 28, 2009
Pharmacokinetics, tolerability of novel bevirimat tablet formulation assessed in HIV patients Oct. 7, 2009
Shionogi and GSK report data from phase II trials of HIV integrase inhibitor S/GSK-1349572 Sep. 28, 2009
RSS